NOEVIR N5 - zinc oxide, octinoxate, titanium dioxide powder 
NOEVIR USA INC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Drug Facts

Drug Facts

Drug Facts
Active Ingredients                       Purpose
ZINC OXIDE  14.25%                  Sunscreen
OCTINOXATE  7.5%                   Sunscreen
TITANIUM DIOXIDE 2.07%         Sunscreen

Uses
Warnings
For external use only.
When using this product
Stop use and ask a doctor if
Keep out of reach of children
Directions
Other Information
Sun Alert
Limiting sun exposure, wearing protective clothing and using sunscreens may reduce the risks of skin aging, skin cancer, and other harmful effects of the sun.

Label image

box image


NOEVIR N5 
zinc oxide, octinoxate, titanium dioxide powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62908-012
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE144 mg  in 100 g
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE2000 mg  in 100 g
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE13800 mg  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:62908-012-021 in 1 BOX
1NDC:62908-012-0112 g in 1 TRAY
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/01/2010
Labeler - NOEVIR USA INC (018593293)
Registrant - NOEVIR USA INC (018593293)
Establishment
NameAddressID/FEIBusiness Operations
NOEVIR CO Ltd690620521manufacture

Revised: 12/2009
Document Id: db90c8b8-d187-4480-be9b-95273150a11d
Set id: c07068f0-6c0c-445f-869c-97809131cb80
Version: 1
Effective Time: 20091208
 
NOEVIR USA INC